Literature DB >> 6944531

Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells.

P G Natali, K Imai, B S Wilson, A Bigotti, R Cavaliere, M A Pellegrino, S Ferrone.   

Abstract

The hybridoma 653.40S, constructed with splenocytes from an inbred BALB/c mouse immunized with cultured human melanoma cells, secreted an antibody that had been shown to recognize an antigenic determinant restricted to human melanoma cell lines. The monoclonal antibody (MoAb) 653.40S showed immunoprecipitation of two glycopolypeptides synthesized by melanoma cells, one with the apparent molecular weight of 280,000 and the other one with a molecular weight larger than 500.000. These two glycopolypeptides were not bridged by disulfide bonds and were peripheral rather than integral to the plasma cell membrane. Comparison of the reactivity of cells of the melanocyte lineage with the MoAb 653.40S and with the MoAb Q5/13 to human Ia-like antigens showed that the former reacted with proliferating melanocytes and melanoma cells, whereas the latter reacted only with melanoma cells. The MoAb 653.40S did not react with a large variety of surgically removed normal and tumor tissues except for some instances of basal cell and squamous cell carcinomas. These results suggested that double staining of pigmented skin lesions with the MoAb 653.40S and with an MoAb to Ia-like antigens may help to solve controversial diagnosis of melanoma. Furthermore, the MoAb 653.40S may be useful for radioimaging and immunotherapy of melanoma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6944531

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments.

Authors:  J Bomanji; J L Hungerford; M Granowska; K E Britton
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

2.  A monoclonal antibody specific for cells of the melanocyte lineage.

Authors:  C Vennegoor; P Hageman; H Van Nouhuijs; D J Ruiter; J Calafat; P J Ringens; P Rümke
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

3.  Immunohistological detection of human malignant melanoma using monoclonal antibody to a melanoma-associated antigen.

Authors:  T Kageshita; M Johno; T Ono; T Arao; K Imai
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

4.  Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera.

Authors:  B S Wilson; N E Kay; K Imai; S Ferrone
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

5.  Retrovirus targeting by tropism restriction to melanoma cells.

Authors:  F Martin; S Neil; J Kupsch; M Maurice; F Cosset; M Collins
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Selective in vitro toxicity of purothionin conjugated to the monoclonal antibody 225.28S to a human high-molecular-weight melanoma-associated antigen.

Authors:  K Imai; T Nakanishi; T Noguchi; A Yachi; S Ferrone
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

7.  Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies.

Authors:  L Suter; E B Bröcker; J Brüggen; D J Ruiter; C Sorg
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. An immunohistochemical study on paraffin sections.

Authors:  R Colombari; F Bonetti; G Zamboni; A Scarpa; F Marino; A Tomezzoli; P Capelli; F Menestrina; M Chilosi; L Fiore-Donati
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

9.  Targeted retroviral infection of tumor cells by receptor cooperation.

Authors:  Francisco Martin; Simon Chowdhury; Stuart J Neil; Kerry A Chester; Francois-Loic Cosset; Mary K Collins
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.

Authors:  L Ferradini; A Mackensen; C Genevée; J Bosq; P Duvillard; M F Avril; T Hercend
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.